Ablynx to receive milestone for bi-specific nanobody in oncology

New approaches in cancer research

Tumour-on-chip model supports preclinical drug development on pancreatic cancer

New methods for reliable evaluation of chemicals and pharmaceuticals

18 partners from eight countries are working on the introduction of innovative methods for evaluating safety and efficacy without animal testing

“Multi Organ Model” - Animal-free alternative for pharmacokinetics research

Dynamic42 and research partners present three-organ system to reduce animal testing

Millions in funding for the development of a novel drug against multi-resistant bacteria

Infex and Justus-Liebig-University Giessen awarded £1 million grant from PACE

Stockholm-based biotech start-up aims to develop the next generation of cell therapies

Neogap Therapeutics' PIOR technology identifies targets for personalised liver cancer immunotherapies

European startups at the forefront of the fight against cancer

With nearly 1,500 entities, Europe hosts a larger number of cancer-related startups than the US

BioMed X Institute launches new cancer collaboration with Daiichi Sankyo

Call for proposals from researchers around the world to take part in this ambitious project

QUANTRO Therapeutics achieves breakthrough in transcriptomic drug discovery

First successful simultaneous 10-target multiplex-screening

Nobel Prize in Chemistry: How protein discoveries benefit research at BASF

Computational protein design and protein structure prediction speed up day-to-day research

Siegfried opens new global R&D Center for Drug Substances in Evionnaz

New facility to drive development excellence and further growth

Without using animals: antibodies from algae for pregnancy tests

Start-up develops new process - DBU provides funding

QIAGEN collaborates with McGill University to advance microbiome research

Small German start-up develops bluetongue virus vaccine within a few months

Verovaccines leverages its new capabilities for rapid emergency response and cost-effective classical animal health vaccine development

Study confirms effectiveness of the new Omikron booster

Biontech vaccine activated for booster vaccination against the current Corona variant JN.1 Production of adapted antibodies

Bayer awards incubator opportunity to Genvor

Critical resources will help Genvor to grow and scale biological crop protection products and innovative trait technologies

First-of-its-kind vaccine expands malaria protection for pregnant women

Sanaria® PfSPZ Vaccine protects women against malaria before and during pregnancy for at least two years

CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma

First patient administered in dose-confirmation Part B of Phase 1 study with mRNA-based, multiepitope cancer vaccine candidate CVGBM

Sharpening the gene scissors together

Max Delbrück Centre and biotech start-up AlgenScribe cooperate

A new understanding of enzymatic catalysis

BASF and the University of Graz develop fundamentally new computer-assisted model to optimize efficiency of biocatalytic production processes

Evotec and Pfizer collaborate to advance drug discovery in France

Multi-year collaboration will initially focus on early discovery research for metabolic and infectious diseases

Natural substance spray against pulmonary fibrosis

Project receiving 800,000 euros from the biomedical start-up incubator IBT Lower Saxony

Rare side effect discovered in cancer immunotherapy

Fascinating new findings: Obesity starts in the brain

Even a short-term intake of highly processed, unhealthy foods can lead to serious changes in the brain

Antimalarial drug together with anticancer drug is efficient against leukemia

Combination of approved drugs offers new strategies for acute myeloid leukemia

A method to purify proteins with light

Gentler and more efficient than previous procedures

A molecular fountain of youth for the brain

Ageing processes in “mini-brains” observed for the first time

“Multi Organ Model” - Animal-free alternative for pharmacokinetics research

Dynamic42 and research partners present three-organ system to reduce animal testing

Potential target for MS therapy discovered

Smoking and antibiotic resistance: How cigarette waste promotes the spread of resistant germs

Smoking becomes an indirect health risk

Extreme Mutation Hotspot in Bacteria Discovered: Study Links High Mutation Rates to Transcriptional Activation

Groundbreaking research identifies a 5000-fold increase in mutation rates in the promoter of a bacterial gene

Groundbreaking AI tool generates 3D map of the brain

It is a detailed view of the brain like never seen before: allowing users to zoom in and out — from all angles, like a Google Earth map

New methods for reliable evaluation of chemicals and pharmaceuticals

18 partners from eight countries are working on the introduction of innovative methods for evaluating safety and efficacy without animal testing

Complete breakdown of PMMA plastic into its building blocks

Surprisingly simple process

Pineapple juice is scarce and expensive due to a small harvest

Analyze odorous substances without errors

Comparative study confirms established method as gold standard

Converting CO2 into fuel – with the help of battery waste

Upcycling as a climate game-changer: A nanocatalyst has been produced based on spent batteries and aluminium foil residues, converting CO2 into valuable methane

Eating walnuts for breakfast may boost your brain function

Super-sensitive spray-on explosive detector

Triple Bond Formed Between Boron and Carbon for the First Time

Researchers are opening up new horizons in chemistry: They present the world's first triple bond between the atoms boron and carbon

Eating mangos daily shown to improve insulin sensitivity and blood glucose control

New research finds mangos may be key to reducing insulin resistance in adults who are overweight or obese

Just take a photo to determine the chemical composition

Chemists use machine learning and robotics to identify chemical compositions from images

Important technological milestone: production of sustainable aviation fuel becomes more efficient

KIT and Sunfire succeed in Kopernikus project P2X technology upgrade for CO2-neutral production of fuels

What happens when a diet targets ultra-processed foods?

Scientists patent corrosion-resistant nano-coating for metals

Thinner, less toxic than existing coatings; efficient and economical to produce

Engineers discover key barrier to longer-lasting batteries

University of Texas at Dallas researchers have discovered why LiNiO2 batteries break down

From research to startup: Polybot receives order for AI-based harvesting robotics

"The Polybot project leverages recent breakthroughs in machine learning to make polyculture farming economically viable"

Researchers are cracking the code on solid-state batteries

Using a combination of advanced imagery and ultra-thin coatings, researchers are working to revolutionize solid-state battery performance

We strip bare

Tony's Chocolonely makes a statement for transparency in supply chains with a "half-naked" chocolate bar

Solving the case of the missing platinum

Volcafe and Cotierra partner to generate carbon credits from biochar within coffee value chains

Partnership marks pioneering advance for Colombian coffee farmers

Potential for significant defossilisation of the chemical industry using biomass

Study Confirms Biomass Can Meet 20% of Carbon Demand in Chemicals Sector by 2050 without compromising food and feed supply

With bird flu in raw milk, many in U.S. still do not know risks of consuming it

PFAS: Found 180 times more ‘forever chemicals’ in birds

New technology allows for much more precise measurements of these chemicals in organisms

AI food scanner turns phone photos into nutritional analysis

NYU Tandon researchers develop technology to calculate calories and nutrients from food images

From raw material to an (almost) finished car battery

Successful European battery project

Acai start-up The Rainforest Company is insolvent

Financial problems and investor dispute lead to the end